Clinical Trial

Dupilumab Effects Against Aeroallergen Challenge

Name: Dupilumab Effects Against Aeroallergen Challenge — clinical trial record (NCT05720325)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The trial involves two interventions: (i) exposure to HDM in the ACC and (ii) administration of dupilumab/placebo for dupilumab.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-16

Trial Details

NCT Number	NCT05720325
Lead Sponsor	The University of Texas Health Science Center at San Antonio Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), Regeneron Pharmaceuticals
Conditions	Asthma, Allergic
Enrollment	96 participants
Start Date	2023-03-29
Primary Completion	2026-11-01 (estimated)
Study Completion	2027-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-11